Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury

Area of Science:

• Cardiology
• Hepatology
• Internal Medicine

Background:

• The association between liver cirrhosis and heart disease, particularly coronary artery disease (CAD), is increasingly recognized.
• Significant data gaps exist regarding atherosclerosis and ischemic heart disease in patients with liver cirrhosis.
• Metabolic syndrome and non-alcoholic fatty liver disease contribute to the complexity of managing comorbid heart and liver conditions.

Purpose of the Study:

• To review the current literature on the prevalence, risk assessment, and treatment of coronary artery disease in patients with liver cirrhosis.
• To highlight the epidemiological and pathophysiological links between liver cirrhosis and ischemic heart disease.
• To emphasize the need for a multidisciplinary approach in managing these complex patients.

Main Methods:

• Systematic literature review of studies investigating heart disease in liver cirrhosis patients.
• Analysis of epidemiological data, risk factors, and diagnostic challenges.
• Evaluation of current medical and interventional treatment strategies.

Main Results:

• Liver cirrhosis is associated with increased rates of morbidity and all-cause mortality, largely due to comorbid cardiovascular conditions like CAD.
• Prevalence and risk assessment data for CAD in liver cirrhosis patients are still evolving.
• Effective management requires tailored strategies considering both liver and heart conditions.

Conclusions:

• A collaborative heart-liver team approach is essential for optimal patient management.
• Early detection and primary prevention of coronary artery disease can significantly improve the prognosis for individuals with liver cirrhosis.
• Further research is needed to fully elucidate the complex interplay between liver cirrhosis and cardiovascular disease.